LABS.TO MEDIPHARM LABS CORP
$0.08▲ +0.00%
Healthcare
Other
Volume 115.6K
Avg Volume (10D) 83.2K
Key Metrics & Fundamentals
Market Cap
$32.04M
P/E Ratio
–
Div Yield
–%
52W Range
0.06 - 0.10
% vs 50 MA
-1.00%
% vs 200 MA
4.12%
RSI-14
47.6
MACD Histogram
+0.0000
Beta (1Y vs SPY)
0.66
Free Cash Flow
-$825,000
Gross Rev
$8.96M
Gross Profit
$3.32M
EBITDA
-$470,000
COGS
$5.64M
Operating Exp
$4.23M
Operating Income
-$912,000
EBIT
-$912,000
Pretax Income
-$867,000
Net Income
-$867,000
EPS (Diluted)
0.00
Price & Volume History
Loading chart…
Recent News
MediPharm Labs Corp (MEDIF) (Q2 2026) Earnings Call Highlights: First Profitable Quarter Since ...
GuruFocus.com · Aug 13, 2026 11:03 PM
MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA
GlobeNewswire · Aug 13, 2026 11:30 AM
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results
GlobeNewswire · Aug 10, 2026 10:30 PM
MediPharm Reports Positive Phase 2 LiBBY Trial Results in Patients With Advanced Dementia
MT Newswires · Jul 14, 2026 3:11 PM
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced Alzheimer’s Disease and Dementia
GlobeNewswire · Jul 14, 2026 12:35 PM
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
GlobeNewswire · Jun 17, 2026 11:30 PM
Financial Overview - Income Statement
Quarterly
Mar 2026
See LABS.TO's money flow as a full page
Social Sentiment
No Reddit posts found for LABS.TO.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.